Henan Taloph Pharmaceutical Stock Co.,Ltd. Posted 58.3 Million Yuan Net Loss in First Three Quarters of 2022

Henan Taloph Pharmaceutical Stock Co.,Ltd. (河南太龙药业股份有限公司) (600222.SH) reported a net loss of 58.3 million yuan in the first three quarters of 2022, reversing a net profit of 29.1 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 16% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 54.6%.